Human LAG3/CD223 protein (Recombinant) (C-His-Avi) {Biotin} (STJP001632)

SPECIFICATIONS
HostHEK293
ConjugationBiotin
ImmunogenDNA sequence encoding Human LAG3/CD223 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
STJP001632
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Human LAG3/CD223-C-His-Avi protein was developed from hek293 and has a target region of C-His-Avi. For use in research applications.
HostHEK293
NoteSTRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationBiotin
Dilution RangeUpon receipt centrifuge vial to ensure maximal product extraction, recommended: 20sec, 5K RPM
FormulationLyophilised from 0.2 µm filtered PBS solution pH7.4.
Storage InstructionThe lyophilized protein is stable for at least 1 year from date of receipt at-20°C.
EndotoxinEndotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg).

Target Information

Gene SymbolLAG3
Gene ID3902
Uniprot IDLAG3_HUMAN
ImmunogenDNA sequence encoding Human LAG3/CD223 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
Immunogen RegionLeu23-Gly434

Additional Info

Post Translational Modifications Lymphocyte activation gene 3 protein: Proteolytically cleaved by ADAM10 and ADAM17 within the connecting peptide region, leading to release of Secreted lymphocyte activation gene 3 protein (sLAG-3). ADAM10 mediates constitutive cleavage, but cleavage increases following T-cell activation, whereas shedding by ADAM17 is induced by TCR signaling in a PRKCQ-dependent manner.
Function Lymphocyte activation gene 3 protein: Inhibitory receptor on antigen activated T-cells. Delivers inhibitory signals upon binding to ligands, such as FGL1. FGL1 constitutes a major ligand of LAG3 and is responsible for LAG3 T-cell inhibitory function. Following TCR engagement, LAG3 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation. May inhibit antigen-specific T-cell activation in synergy with PDCD1/PD-1, possibly by acting as a coreceptor for PDCD1/PD-1. Negatively regulates the proliferation, activation, effector function and homeostasis of both CD8(+) and CD4(+) T-cells. Also mediates immune tolerance: constitutively expressed on a subset of regulatory T-cells (Tregs) and contributes to their suppressive function. Also acts as a negative regulator of plasmacytoid dendritic cell (pDCs) activation. Binds MHC class II (MHC-II).the precise role of MHC-II-binding is however unclear. Secreted lymphocyte activation gene 3 protein: May function as a ligand for MHC class II (MHC-II) on antigen-presenting cells (APC), promoting APC activation/maturation and driving Th1 immune response.
Protein Name Lymphocyte Activation Gene 3 Protein
Lag-3
Cd Antigen Cd223 Cleaved Into - Secreted Lymphocyte Activation Gene 3 Protein
Slag-3
Database Links Reactome: R-HSA-2132295
Cellular Localisation Lymphocyte Activation Gene 3 Protein: Cell Membrane
Single-Pass Type I Membrane Protein
Secreted Lymphocyte Activation Gene 3 Protein: Secreted
Produced Following Cleavage Of The Main Chain
Alternative Protein Names Lymphocyte Activation Gene 3 Protein protein
Lag-3 protein
Cd Antigen Cd223 Cleaved Into - Secreted Lymphocyte Activation Gene 3 Protein protein
Slag-3 protein
LAG3 protein
FDC protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins